Header Logo

Connection

James Bremer to HIV-1

Back to Details
This is a "connection" page, showing publications James Bremer has written about HIV-1.
James Bremer
Connection Strength
5.566
HIV-1
  1. Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing. Viruses. 2020 12 17; 12(12).
    View in: PubMed
    Score: 0.573
  2. The stability of HIV-1 nucleic acid in whole blood and improved detection of HIV-1 in alternative specimen types when compared to Dried Blood Spot (DBS) specimens. J Virol Methods. 2018 11; 261:91-97.
    View in: PubMed
    Score: 0.487
  3. Use of External Quality Control Material for HIV-1 RNA Testing To Assess the Comparability of Data Generated in Separate Laboratories and the Stability of HIV-1 RNA in Samples after Prolonged Storage. J Clin Microbiol. 2018 06; 56(6).
    View in: PubMed
    Score: 0.480
  4. Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation. J Clin Microbiol. 2012 Aug; 50(8):2737-47.
    View in: PubMed
    Score: 0.318
  5. Complex mosaic composition of near full-length genomes of two NED (NIH-ENVA-DOD) subtype panel HIV type 1 strains, BCF-Dioum and BCF-Kita, originating from the Democratic Republic of Congo (DRC). AIDS Res Hum Retroviruses. 2009 Oct; 25(10):1039-43.
    View in: PubMed
    Score: 0.263
  6. Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity. J Antimicrob Chemother. 2009 Jul; 64(1):33-6.
    View in: PubMed
    Score: 0.256
  7. Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. J Clin Microbiol. 2005 Dec; 43(12):5950-6.
    View in: PubMed
    Score: 0.202
  8. Stability of human immunodeficiency virus type 1 proviral DNA in whole-blood samples. J Clin Microbiol. 2005 Aug; 43(8):4249-50.
    View in: PubMed
    Score: 0.197
  9. Comparison of the sensitivities of the version 1.5 and version 1.0 ultrasensitive Roche AMPLICOR HIV-1 MONITOR kits at low concentrations of human immunodeficiency virus RNA. J Clin Microbiol. 2004 Jun; 42(6):2819-20.
    View in: PubMed
    Score: 0.182
  10. Evaluation of the editing process in human immunodeficiency virus type 1 genotyping. J Clin Microbiol. 2003 Jul; 41(7):3265-72.
    View in: PubMed
    Score: 0.171
  11. Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel. AIDS Res Hum Retroviruses. 2003 Apr; 19(4):321-8.
    View in: PubMed
    Score: 0.168
  12. Ratio of two successive optical densities from the Roche HIV-1 monitor test as a measure of accuracy of estimates of human immunodeficiency virus RNA concentration. J Clin Microbiol. 2002 Mar; 40(3):1067-8.
    View in: PubMed
    Score: 0.156
  13. Prevalent subtypes and one-year outcomes of an HIV-cohort from an urban Philippine center. Medicine (Baltimore). 2021 Dec 23; 100(51):e28315.
    View in: PubMed
    Score: 0.154
  14. Effect of errors in the sequence of optical densities from the Roche AMPLICOR HIV-1 MONITOR assay on the validity of assay results. J Clin Microbiol. 2001 Mar; 39(3):1118-20.
    View in: PubMed
    Score: 0.145
  15. Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche AMPLICOR HIV-1 MONITOR assays. J Clin Microbiol. 2001 Mar; 39(3):1121-3.
    View in: PubMed
    Score: 0.145
  16. Comparison of two amplification technologies for detection and quantitation of human immunodeficiency virus type 1 RNA in the female genital tract. Division of AIDS Treatment Research Initiative 009 Study Team. J Clin Microbiol. 2000 Jul; 38(7):2665-9.
    View in: PubMed
    Score: 0.139
  17. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr. 1996 Aug; 129(2):198-207.
    View in: PubMed
    Score: 0.106
  18. Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity. J Clin Microbiol. 2015 Aug; 53(8):2659-66.
    View in: PubMed
    Score: 0.098
  19. Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network. Clin Infect Dis. 2012 May; 54 Suppl 4:S273-9.
    View in: PubMed
    Score: 0.079
  20. Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis. J Clin Microbiol. 2009 Nov; 47(11):3530-9.
    View in: PubMed
    Score: 0.065
  21. Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to -20 degrees C. J Clin Microbiol. 2008 Sep; 46(9):2945-9.
    View in: PubMed
    Score: 0.060
  22. Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue. Virology. 2007 Dec 05; 369(1):55-68.
    View in: PubMed
    Score: 0.057
  23. Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J Clin Microbiol. 2007 Feb; 45(2):517-21.
    View in: PubMed
    Score: 0.054
  24. Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity. FEMS Immunol Med Microbiol. 2006 Nov; 48(2):267-73.
    View in: PubMed
    Score: 0.053
  25. Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol. 2006 Jul; 44(7):2612-4.
    View in: PubMed
    Score: 0.053
  26. Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assays. J Clin Microbiol. 2005 Aug; 43(8):3963-70.
    View in: PubMed
    Score: 0.049
  27. Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals. FEMS Immunol Med Microbiol. 2005 Aug 01; 45(2):129-36.
    View in: PubMed
    Score: 0.048
  28. Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis. 2004 Dec 01; 190(11):1970-8.
    View in: PubMed
    Score: 0.047
  29. HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course. J Acquir Immune Defic Syndr. 2003 Dec 15; 34(5):491-6.
    View in: PubMed
    Score: 0.044
  30. HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc Natl Acad Sci U S A. 2003 Oct 28; 100(22):12972-7.
    View in: PubMed
    Score: 0.044
  31. Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J Clin Microbiol. 2003 May; 41(5):1888-93.
    View in: PubMed
    Score: 0.042
  32. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women. J Infect Dis. 2003 Feb 01; 187(3):375-84.
    View in: PubMed
    Score: 0.041
  33. Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter. J Clin Microbiol. 2002 Jun; 40(6):2089-94.
    View in: PubMed
    Score: 0.040
  34. Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program. AIDS Res Hum Retroviruses. 2002 Mar 01; 18(4):243-8.
    View in: PubMed
    Score: 0.039
  35. Longitudinal variability of human immunodeficiency virus type 1 RNA viral load measurements by nucleic acid sequence-based amplification and NucliSens assays in a large multicenter study. J Clin Microbiol. 2001 Oct; 39(10):3760-3.
    View in: PubMed
    Score: 0.038
  36. Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group. J Clin Microbiol. 2000 Oct; 38(10):3822-4.
    View in: PubMed
    Score: 0.035
  37. Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient? J Leukoc Biol. 2000 Sep; 68(3):324-30.
    View in: PubMed
    Score: 0.035
  38. Investigation of effects of acid citrate dextrose and EDTA on ability to quantitatively culture human immunodeficiency virus. J Clin Microbiol. 2000 Sep; 38(9):3522.
    View in: PubMed
    Score: 0.035
  39. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2000 Aug; 38(8):2837-45.
    View in: PubMed
    Score: 0.035
  40. Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasma. J Clin Microbiol. 2000 Jun; 38(6):2348-53.
    View in: PubMed
    Score: 0.034
  41. The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program. AIDS. 1999 Nov 12; 13(16):2269-79.
    View in: PubMed
    Score: 0.033
  42. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. AIDS. 1999 Sep 10; 13(13):1717-26.
    View in: PubMed
    Score: 0.033
  43. Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health care worker occupational exposures. JAMA. 1999 Mar 24-31; 281(12):1085-6.
    View in: PubMed
    Score: 0.032
  44. Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol. 1998 Jun; 36(6):1471-9.
    View in: PubMed
    Score: 0.030
  45. Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisons. J Clin Microbiol. 1998 Jan; 36(1):311-4.
    View in: PubMed
    Score: 0.029
  46. Stabilities of free and complexed human immunodeficiency virus p24 antigens during short- and long-term storage. J Clin Microbiol. 1997 Sep; 35(9):2413-6.
    View in: PubMed
    Score: 0.028
  47. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med. 1997 Jun 15; 126(12):929-38.
    View in: PubMed
    Score: 0.028
  48. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol. 1996 Nov; 34(11):2695-701.
    View in: PubMed
    Score: 0.027
  49. Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group. J Clin Microbiol. 1996 Sep; 34(9):2312-5.
    View in: PubMed
    Score: 0.027
  50. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. J Clin Microbiol. 1993 Dec; 31(12):3123-8.
    View in: PubMed
    Score: 0.022
  51. Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs. J Infect Dis. 2003 Jul 15; 188(2):209-18.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.